The drug treatment for strategy and selection of osteoporotic fracture

doi:10.3877/cma.j.issn.2096-0263.2018.05.012

Abstract

Abstract:

With the advent of an aging society, the incidence of low-vibration fragility fractures has increased year by year. The application of locking plate and bone cement strengthening techniques in clinical practice has made surgical treatment of osteoporotic fractures no longer difficult. However, continuous studies have confirmed that osteoporotic re-fracture has become another difficult and hot point of treatment. This article summarizes results of previous clinical literature and aims to provide reference for medical workers in the use of anti-osteoporosis drugs in the treatment of osteoporotic fractures.

Key words: Osteoporosis, Disphosphonate, Teriparatide

Zhenwu Gao, Dou Wu, Min Gao, Jian Zhu, Chen Chen, Jiping Sun, Qiang Liu. The drug treatment for strategy and selection of osteoporotic fracture[J]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2018, 04(05): 317-320.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlngkykfdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2096-0263.2018.05.012

https://zhlngkykfdzzz.cma-cmc.com.cn/EN/Y2018/V04/I05/317

References 18

[1]	中华医学会骨科学分会.骨质疏松骨折诊疗指南[J].中华骨科杂志, 2008, 28(10): 875-878.
[2]	邱贵兴，裴福兴，胡侦明,等.中国骨质疏松性骨折诊疗指南（骨质疏松性骨折诊断及治疗原则）[J].中华骨与关节外科杂志, 2015 (5): 371-374.
[3]	Bliuc D, Nguyen ND, Alarkawi D, et al. Accelerated bone loss and increased post-fracture mortality in elderly women and men [J]. Osteoporo Int, 2015, 26(4): 1331-1339.
[4]	孙爱军，林守清，余卫,等.经皮用雌二醇预防中国妇女绝经早期骨丢失[J].中华医学杂志(英文版), 2002, 115(12): 1790-1795.
[5]	Schmder HM, Peterson KK, Erlandsen M. Occurrence and incidence of the second hip fracture [J]. Clin Orthop, 1993, 289: 166-169.
[6]	Goldhahn J, Little D, Mitchell P, et al. Evidence for anti-osteoporosis therapy in acute fracture situations--recommendations of a multidisciplinary workshop of the International Society for Fracture Repair[J]. Bone, 2010, 46(2): 267-271.
[7]	中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊治指南[J].中华骨质疏松和骨矿盐疾病杂志, 2011, 4(1): 2-17.
[8]	吴青，朱汉民.骨质疏松基础防治措施对老年人25羟基维生素D水平和下肢肌力及平衡功能的影响[J].中华老年医学杂志, 2014, 33(10): 1135-1138.
[9]	张秀珍，宣淼，李颖,等.一项为期18个月、多中心应用重组人甲状旁腺激素(1-34)与依降钙素治疗绝经后骨质疏松症的随机、对照临床试验研究[J].中华内分泌代谢杂志, 2015 (2): 120-126.
[10]	李国新，袁忠治，温健,等.口服及静脉应用双磷酸盐治疗绝经后的骨质疏松临床研究[J].中国骨质疏松杂志, 2013, 19(9): 988-990.
[11]	陈琳，游利，陈瑾瑜,等.应用阿仑膦酸钠治疗绝经后骨质疏松失效改用雷洛昔芬的疗效观察[J].中华骨质疏松和骨矿盐疾病杂志, 2015 (2): 132-137.
[12]	Khosla S. Increasing options for the treament of osteoporosis [J]. N Engl J Med, 2009, 361(8): 818-820.
[13]	Cosman F, Eriksen EF, Recknor C, et al. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis [J]. J Bone Miner Res, 2011, 26(3): 503-511.
[14]	Eriksen EF, Keaveny TM, Gallagher ER, et al. Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis [J]. Bone, 2014, 67: 246-256.
[15]	Sone T, Masako I, Fukunaga M, et al. The effects of once-weekly teriparatide on hip geometry assessed by hip structural analysis in postmenopausal osteoporotic women with high fracture risk [J]. Bone, 2014 (64): 75-81.
[16]	余倩，吴晶.骨质疏松症患者药物依从性及影响因素分析[J].中国骨质疏松杂志, 2014, 20(7): 789-794.
[17]	Balasubramanian A, Tosi LL, Lane JM, et al. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009 [J]. J Bone Joint Surg Am, 2014, 96(7): e52.
[18]	Klop C, Gibson-Smith D, Elders PJ, et al. Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010 [J]. Osteoporos Int, 2015, 26(7): 1919-1928.

Please choose a citation manager

Content to export